ASCO® GU 2024 Insights: "Patient Characteristics, Treatment Patterns, and Outcomes Among Early Adopters of 177Lu-PSMA-617 for Prostate Cancer"
By
Dana-Farber Cancer Institute
FEATURING
Xiao Wei
By
Dana-Farber Cancer Institute
FEATURING
Xiao Wei
Login to view comments.
Click here to Login